Ultra Clean (NasdaqGS:UCTT) FY Conference Transcript
2026-01-13 18:47
Ultra Clean (NasdaqGS:UCTT) FY Conference January 13, 2026 12:45 PM ET Company ParticipantsJames Scholhamer - CEOConference Call ParticipantsNone - Analyst 2Charles Shi - Semi-cap AnalystNone - Analyst 1Charles ShiAll right. Good afternoon. Welcome to the 28th Annual Needham Growth Conference. My name is Charles Shi. I'm the semi-cap analyst at Needham. Joining me on the stage is Ultra Clean's CEO, Mr. James Scholhamer. And James, I think this is your first time here, I believe. And thank you very much for ...
McKesson (NYSE:MCK) FY Conference Transcript
2026-01-13 18:47
McKesson (NYSE:MCK) FY Conference January 13, 2026 12:45 PM ET Company ParticipantsLisa Gill - Head of Healthcare ServicesBritt Vitalone - CFOBrian Tyler - CEOLisa GillGood morning, and thank you for joining us. My name is Lisa Gill, and I head up healthcare services here at JPMorgan. It is with great pleasure this morning that I introduce McKesson. Speaking for McKesson will be CEO Brian Tyler. After that, we will have a fireside chat where Britt Vitalone, CFO, will join us. So with that, let me turn it ov ...
Sionna Therapeutics (NasdaqGM:SION) FY Conference Transcript
2026-01-13 18:47
Sionna Therapeutics (NasdaqGM:SION) FY Conference January 13, 2026 12:45 PM ET Company ParticipantsCharlotte McKee - CMOElena Ridloff - CFOBhavana Balakrishnan - Investment Banking AssociateMike Cloonan - President and CEOConference Call ParticipantsNone - Analyst 2None - Analyst 1Bhavana BalakrishnanGood morning, everybody. Thank you so much for joining us here on Day 2 of the J.P. Morgan Healthcare Conference. My name is Bhavana Balakrishnan. I am an associate with the Healthcare Investment Banking team. ...
ACADIA Pharmaceuticals (NasdaqGS:ACAD) FY Conference Transcript
2026-01-13 18:47
ACADIA Pharmaceuticals (NasdaqGS:ACAD) FY Conference January 13, 2026 12:45 PM ET Company ParticipantsElizabeth Thompson - Head of R&DCatherine Owen Adams - CEOThomas Garner - Chief Commercial OfficerMark Schneyer - CFOConference Call ParticipantsTessa Romero - Senior Biotech AnalystTessa RomeroWelcome, everyone, to the 44th Annual JPMorgan Healthcare Conference. My name is Tess Romero, and I'm one of the Senior Biotech Analysts here at JPMorgan. Our next presenting company is ACADIA Pharmaceuticals, and pr ...
Royalty Pharma (NasdaqGS:RPRX) FY Conference Transcript
2026-01-13 18:47
Royalty Pharma (NasdaqGS:RPRX) FY Conference January 13, 2026 12:45 PM ET Company ParticipantsChris Schott - Managing DirectorPablo Legorreta - Founder & CEONone - Company RepresentativeConference Call ParticipantsNone - AnalystChris SchottGood morning, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be introducing Royalty Pharma today. It's a really unique business in our view, a company that's helping finance a lot of the innovation that's occurring across the biopharma space. From the co ...
LendingTree (NasdaqGS:TREE) FY Conference Transcript
2026-01-13 18:47
LendingTree (NasdaqGS:TREE) FY Conference January 13, 2026 12:45 PM ET Company ParticipantsScott Peyree - CEOAndrew Wessel - Head of Investor RelationsConference Call ParticipantsNone - AnalystMayank Tandon - AnalystMayank TandonHello everyone. My name is Mayank Tandon, and I cover fintech at Needham. I'd like to welcome LendingTree to our conference. We have Scott Peyree, the CEO, and Andrew Wessel, Head of Investor Relations. Thank you for joining us. Scott PeyreeNice to be here. Thank you.Mayank TandonTe ...
EVgo (NasdaqGS:EVGO) FY Conference Transcript
2026-01-13 18:47
EVgo (NasdaqGS:EVGO) FY Conference January 13, 2026 12:45 PM ET Company ParticipantsBadar Khan - CEOConference Call ParticipantsChristopher - Senior AnalystChristopherOkay. I think we're good to start. Welcome, everyone, to the afternoon session of day one of the 28th Annual Needham Growth Conference. My name is Chris Pierce with the Needham Research Team. It's my pleasure to introduce Badar Khan, CEO of EVgo. Badar, I'd like to give you 30 seconds, a minute or so, just kind of introduce yourself, talk abou ...
Oric Pharmaceuticals (NasdaqGS:ORIC) FY Conference Transcript
2026-01-13 18:47
Oric Pharmaceuticals (NasdaqGS:ORIC) FY Conference January 13, 2026 12:45 PM ET Company ParticipantsJacob Chacko - MD President, CEO, and Board MemberConference Call ParticipantsNone - AnalystAnupam Rama - Managing Director and Senior Equity AnalystAnupam RamaAll right, let's go ahead and get started. Welcome, everyone, to the 44th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by my squad, Rathi Pinhei, Priyanka Grover, and ...
Sandoz Group (OTCPK:SDZN.Y) FY Conference Transcript
2026-01-13 18:47
Sandoz Group (OTCPK:SDZN.Y) FY Conference January 13, 2026 12:45 PM ET Company ParticipantsRemco Steenbergen - CFOPeter Testa - DirectorKaren King - Global Head of Investor RelationsRichard Saynor - CEOConference Call ParticipantsNone - AnalystModeratorGood morning and welcome to the Sandoz session of the 44th JPMorgan Healthcare Conference. My name is Fearne Bon Nelson. I'm an analyst here at JPMorgan on the European Pharma and Biotech team, and today it's my pleasure to welcome CEO of Sandoz, Richard Sayn ...
Novo Nordisk (NYSE:NVO) FY Conference Transcript
2026-01-13 18:47
Novo Nordisk (NYSE:NVO) FY Conference January 13, 2026 12:45 PM ET Company ParticipantsMike Doustdar - CEOConference Call ParticipantsRichard Vosser - European Pharma AnalystRichard VosserWelcome to the Novo Nordisk session at the 26th J.P. Morgan Healthcare Conference. I'm Richard Vosser, European Pharma Analyst at J.P. Morgan, and it's my great pleasure to welcome the new CEO of Novo, Mike Doustdar. He's been CEO for about five months and has been spending that time looking at the strategy, revising the s ...